A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

metformin), 32% (insulin vs. metformin), and 26% (other diabetes drugs vs. metformin). For comparison of monotherapies (Table 3), detectable risk reductions were as follows: 33% (sulfonylurea vs.

The table below provides a comparison of Trulicity ... leads to greater reductions in hemoglobin A1C compared to other diabetes medications, making it an effective choice for many patients.

Lifestyle changes may help manage diabetes for some people. If the condition progresses, you‘re more likely to need medications that keep your blood sugar levels within the standard range.

According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer's ...

According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer’s ...

reviewed claims data from January 2021 to December 2023 to evaluate utilization trends among diabetes medications. The drugs included glucagon-like peptide-1 receptor agonists (Ozempic), glucose ...